Seoul Pharma Co., Ltd (KOSDAQ: 018680)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,365.00
-90.00 (-2.60%)
Dec 20, 2024, 1:54 PM KST

Seoul Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2011 FY 2010 FY 2009 FY 2008 FY 2007 2006 - 2005
Period Ending
Dec '24 Dec '11 Dec '10 Dec '09 Dec '08 Dec '07 2006 - 2005
Market Capitalization
40,22530,31315,62517,0638,50019,375
Upgrade
Market Cap Growth
25.75%94.00%-8.42%100.74%-56.13%-14.84%
Upgrade
Enterprise Value
47,70642,43725,73224,98010,98319,038
Upgrade
Last Close Price
3450.004736.752413.882585.561269.202893.04
Upgrade
PE Ratio
38.1922.7311.0514.4515.68-
Upgrade
PS Ratio
0.740.690.390.540.341.16
Upgrade
PB Ratio
1.031.490.800.940.561.34
Upgrade
P/TBV Ratio
1.841.740.901.020.611.44
Upgrade
P/FCF Ratio
--18.83---
Upgrade
P/OCF Ratio
9.396.247.1313.82--
Upgrade
EV/Sales Ratio
1.130.970.640.790.441.14
Upgrade
EV/EBITDA Ratio
--7.4410.848.27-
Upgrade
EV/EBIT Ratio
30.1222.5010.1420.1635.85-
Upgrade
EV/FCF Ratio
--31.01---
Upgrade
Debt / Equity Ratio
1.350.740.570.550.420.15
Upgrade
Debt / EBITDA Ratio
--3.224.364.72-
Upgrade
Debt / FCF Ratio
--13.42---
Upgrade
Asset Turnover
0.851.071.071.001.020.76
Upgrade
Inventory Turnover
4.094.184.414.344.393.48
Upgrade
Quick Ratio
0.901.311.611.622.272.30
Upgrade
Current Ratio
1.241.812.192.042.682.83
Upgrade
Return on Equity (ROE)
5.12%6.70%7.52%7.10%3.67%-15.98%
Upgrade
Return on Assets (ROA)
1.99%2.89%4.20%2.44%0.79%-8.14%
Upgrade
Return on Capital (ROIC)
2.38%3.57%5.40%3.12%1.01%-10.74%
Upgrade
Earnings Yield
3.35%4.40%9.05%6.92%6.38%-12.95%
Upgrade
FCF Yield
-26.23%-1.90%5.31%-28.57%-36.25%-14.94%
Upgrade
Dividend Yield
0.00%--1.55%--
Upgrade
Payout Ratio
35.60%23.44%17.69%---
Upgrade
Total Shareholder Return
--1.55%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.